Gene:
AMPD3
adenosine monophosphate deaminase 3

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no clinical annotations for this gene. To report clinical variants, click here.

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

Overview

Alternate Names:  erythrocyte-specific AMP deaminase
Alternate Symbols:  None
PharmGKB Accession Id: PA24778

Details

Cytogenetic Location: chr11 : p15.4 - p15.4
GP mRNA Boundary†: chr11 : 10471868 - 10529126
GP Gene Boundary†: chr11 : 10461868 - 10532126
Strand: plus
† The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

PharmGKB contains no curated pathways for this gene. If you would like to volunteer to work on a pathway, please let us know.

External Pathways

Links to non-PharmGKB pathways.

  1. Ribonucleotide salvage - (Reactome via Pathway Interaction Database)